Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation

American Journal of Pathology

Volumn 178, Issue 6, 2011, Pages 2897-2909

  Fuxe, Jonas ^a,d   Tabruyn, Sébastien ^a,e   Colton, Katharine ^a   Zaid, Harras ^a   Adams, Alicia ^a   Baluk, Peter ^a   Lashnits, Erin ^a   Morisada, Tohru ^a   Le, Tom ^a   O'Brien, Shaun ^a   Epstein, David M ^b   Koh, Gou Young ^c   McDonald, Donald M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OSI PHARMACEUTICALS INC   (United States)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; APTAMER; AX 102; BRADYKININ; DESMIN; MICROSPHERE; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL LEAKAGE; CARDIOVASCULAR FUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; INFLAMMATION; MOLECULAR INTERACTION; MOUSE; MYCOPLASMA PULMONIS; MYCOPLASMOSIS; NONHUMAN; PERICYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRACHEA; VASCULAR REMODELING;

EID: 79959376030     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.02.008     Document Type: Article

References (63)

1. Armulik A, Abramsson A, Betsholtz C: Endothelial/pericyte interactions. Circ Res 2005, 97:512-523 (Pubitemid 41361741)
2. Gaengel K, Genove G, Armulik A, Betsholtz C: Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 2009, 29:630-638
3. von Tell D, Armulik A, Betsholtz C: Pericytes and vascular stability. Exp Cell Res 2006, 312:623-629 (Pubitemid 43290338)
4. Speyer CL, Steffes CP, Ram JL: Effects of vasoactive mediators on the rat lung pericyte: quantitative analysis of contraction on collagen lattice matrices. Microvasc Res 1999, 57:134-143 (Pubitemid 29393290)
5. Sims DE: Diversity within pericytes. Clin Exp Pharmacol Physiol 2000, 27:842-846
6. Edelman DA, Jiang Y, Tyburski JG, Wilson RF, Steffes CP: Cytokine production in lipopolysaccharide-exposed rat lung pericytes. J Trauma 2007, 62:89-93 (Pubitemid 46102837)
7. Lindahl P, Johansson BR, Levéen P, Betsholtz C: Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277:242-245 (Pubitemid 27446080)
8. Hellström M, Gerhardt H, Kalen M, Li X, Eriksson U, Wolburg H, Betsholtz C: Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 2001, 153:543-554
9. Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom HC, Bergstrom G, Dejana E, Ostman A, Lindahl P, Betsholtz C: Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 2003, 17:1835-1840 (Pubitemid 36944561)
10. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D: Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 2003, 111:1287-1295 (Pubitemid 36554699)
11. Wilkinson-Berka JL, Babic S, De Gooyer T, Stitt AW, Jaworski K, Ong LG, Kelly DJ, Gilbert RE: Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. Am J Pathol 2004, 164:1263-1273 (Pubitemid 38387793)
12. Sennino B, Falcón BL, McCauley D, Le T, McCauley T, Kurz JC, Haskell A, Epstein DM, McDonald DM: Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102. Cancer Res 2007, 67:7358-7367 (Pubitemid 47206566)
13. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180 (Pubitemid 27010101)
14. Cai J, Kehoe O, Smith GM, Hykin P, Boulton ME: The angiopoietin/ Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Invest Ophthalmol Vis Sci 2008, 49:2163-2171
15. Augustin HG, Koh GY, Thurston G, Alitalo K: Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009, 10:165-177
16. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376:70-74
17. Morisada T, Kubota Y, Urano T, Suda T, Oike Y: Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium 2006, 13:71-79 (Pubitemid 44173109)
18. Fiedler U, Augustin HG: Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 2006, 27:552-558 (Pubitemid 44780853)
19. Nishishita T, Lin PC: Angiopoietin 1, PDGF-B, and TGF-beta gene regulation in endothelial cell and smooth muscle cell interaction. J Cell Biochem 2004, 91:584-593
20. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, Olsen BR, Alitalo K: Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 2008, 10:527-537 (Pubitemid 351627372)
21. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM: Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514
22. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD: Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000, 6:460-463 (Pubitemid 30208166)
23. Baffert F, Le T, Thurston G, McDonald DM: Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am J Physiol Heart Circ Physiol 2006, 290:H107-H118
24. Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, Mostoslavsky G, Ingber DE, Sukhatme VP: Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem 2007, 282:23910-23918 (Pubitemid 47328051)
25. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60 (Pubitemid 27450643)
26. Pfister F, Wang Y, Schreiter K, vom Hagen F, Altvater K, Hoffmann S, Deutsch U, Hammes HP, Feng Y: Retinal overexpression of angiopoietin-mimics diabetic retinopathy and enhances vascular damages in hyperglycemia. Acta Diabetol 2010, 47:59-64
27. Falcón BL, Hashizume H, Koumoutsakos P, Chou J, Bready JV, Coxon A, Oliner JD, McDonald DM: Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels. Am J Pathol 2009, 175:2159-2170
28. McDonald DM: Angiogenesis and vascular remodeling in inflammation and cancer: biology and architecture of the vasculature. Angiogenesis: An Integrative Approach from Science to Medicine. Edited by WD Figg, J Folkman. New York, Springer, 2008, pp 15-31
29. Thurston G, Murphy TJ, Baluk P, Lindsey JR, McDonald DM: Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am J Pathol 1998, 153:1099-1112 (Pubitemid 28465833)
30. Thurston G, Maas K, Labarbara A, McLean JW, McDonald DM: Microvascular remodelling in chronic airway inflammation in mice. Clin Exp Pharmacol Physiol 2000, 27:836-841
31. Fuxe J, Lashnits E, O'Brien S, Baluk P, Tabruyn SP, Kuhnert F, Kuo C, Thurston G, McDonald DM: Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation. Am J Pathol 2010, 176:2009-2018
32. McDonald DM: Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001, 164:S39-S45
33. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, Ylä-Herttuala S, Jackson DG, Alitalo K, McDonald DM: Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005, 115:247-257 (Pubitemid 40385467)
34. Aurora AB, Baluk P, Zhang D, Sidhu SS, Dolganov GM, Basbaum C, McDonald DM, Killeen N: Immune complex-dependent remodeling of the airway vasculature in response to a chronic bacterial infection. J Immunol 2005, 175:6319-6326 (Pubitemid 41598871)
35. Cho CH, Kim KE, Byun J, Jang HS, Kim DK, Baluk P, Baffert F, Lee GM, Mochizuki N, Kim J, Jeon BH, McDonald DM, Koh GY: Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow [Erratum appeared in Circ Res 2006; 98: e69]. Circ Res 2005, 97:86-94
36. Thurston G, Wang Q, Baffert F, Rudge J, Papadopoulos N, Jean-Guillaume D, Wiegand S, Yancopoulos GD, McDonald DM: Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development 2005, 132:3317-3326 (Pubitemid 41167158)
37. Sims DE: Recent advances in pericyte biology-implications for health and disease. Can J Cardiol 1991, 7:431-443
38. Hammes HP: Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res 2005, 37 Suppl 1:39-43
39. Pfister F, Feng Y, vom Hagen F, Hoffmann S, Molema G, Hillebrands JL, Shani M, Deutsch U, Hammes HP: Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 2008, 57:2495-2502
40. Hwang SJ, Kim SH, Kim HZ, Steinmetz MO, Koh GY, Lee GM: High-level expression and purification of a designed angiopoietin-1 chimeric protein, COMP-Ang1, produced in Chinese hamster ovary cells. Protein J 2008, 27:319-326
41. Davidson MK, Davis JK, Lindsey JR, Cassell GH: Clearance of different strains of Mycoplasma pulmonis from the respiratory tract of C3H/HeN mice. Infect Immun 1988, 56:2163-2168
42. Davidson MK, Lindsey JR, Parker RF, Tully JG, Cassell GH: Differences in virulence for mice among strains of Mycoplasma pulmonis. Infect Immun 1988, 56:2156-2162
43. Ezaki T, Baluk P, Thurston G, La Barbara A, Woo C, McDonald DM: Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am J Pathol 2001, 158:2043-2055 (Pubitemid 32545190)
44. Baffert F, Thurston G, Rochon-Duck M, Le T, Brekken R, McDonald DM: Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels. Circ Res 2004, 94:984-992 (Pubitemid 38490077)
45. Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, Hu-Lowe D, McDonald DM: Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 2006, 290:H547-H559
46. Yao LC, Baluk P, Feng J, McDonald DM: Steroid-resistant lymphatic remodeling in chronically inflamed mouse airways. Am J Pathol 2010, 176:1525-1541
47. Kwan ML, Gómez AD, Baluk P, Hashizume H, McDonald DM: Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P. Am J Physiol Lung Cell Mol Physiol 2001, 280:L286-L297
48. Tabruyn SP, Colton K, Morisada T, Fuxe J, Wiegand SJ, Thurston G, Coyle AJ, Connor J, McDonald DM: Angiopoietin-2-driven vascular remodeling in airway inflammation. Am J Pathol 2010, 177:3233-3243
49. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD: Increased vascularization in mice overexpressing angiopoietin-1. Science 1998, 282:468-471 (Pubitemid 28483672)
50. Kim KE, Cho CH, Kim HZ, Baluk P, McDonald DM, Koh GY: In vivo actions of angiopoietins on quiescent and remodeling blood and lymphatic vessels in mouse airways and skin. Arterioscler Thromb Vasc Biol 2007, 27:564-570
51. Ding R, Darland DC, Parmacek MS, D'Amore PA: Endothelial-mesenchymal interactions in vitro reveal molecular mechanisms of smooth muscle/pericyte differentiation. Stem Cells Dev 2004, 13:509-520 (Pubitemid 39473581)
52. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, Naldini L: Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005, 8:211-226 (Pubitemid 41317592)
53. Ozerdem U, Alitalo K, Salven P, Li A: Contribution of bone marrowderived pericyte precursor cells to corneal vasculogenesis. Invest Ophthalmol Vis Sci 2005, 46:3502-3506 (Pubitemid 44264649)
54. Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G: PDGFRbeta(+) perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 2005, 7:870-879 (Pubitemid 41486287)
55. Lamagna C, Bergers G: The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol 2006, 80:677-681 (Pubitemid 44835880)
56. Hellström M, Kalén M, Lindahl P, Abramsson A, Betsholtz C: Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047-3055 (Pubitemid 29378170)
57. Levéen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C: Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 1994, 8:1875-1887 (Pubitemid 24273888)
58. Soriano P: Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 1994, 8:1888-1896
59. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM: Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002, 160:985-1000 (Pubitemid 34224587)
60. Gerhardt H, Semb H: Pericytes: gatekeepers in tumour cell metastasis? J Mol Med 2008, 86:135-144 (Pubitemid 351172122)
61. Puri MC, Partanen J, Rossant J, Bernstein A: Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development 1999, 126:4569-4580
62. Jones N, Voskas D, Master Z, Sarao R, Jones J, Dumont DJ: Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep 2001, 2:438-445 (Pubitemid 32509961)
63. Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, Takagi H, Honda Y, Wiegand SJ, Yancopoulos GD, Nishikawa S: Recombinant angiopoietin-restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 2002, 110:1619-1628 (Pubitemid 35424240)